|
COPYRIGHT 2006 Asia Pulse Pty Ltd
NEW DELHI, March 28 Asia Pulse - India's largest drug maker, Ranbaxy Laboratories Limited (BSE:500359) on Monday said it will acquire the unbranded generic business of Allen SpA, a division of GlaxoSmithKline (GSK), in Italy.
The acquisition, to be done through Ranbaxy's Italian subsidiary, Ranbaxy Italia S.p.A, will come...
Read the full article for free courtesy of your local library.
|